Literature DB >> 9348115

Subcellular localization of dihydropyrimidine dehydrogenase.

A B Van Kuilenburg1, H Van Lenthe, R J Wanders, A H Van Gennip.   

Abstract

Although dihydropyrimidine dehydrogenase (DPD) has been purified and characterized from liver tissues of various mammals conflicting data exist on its subcellular localization. To determine the localization of DPD we prepared crude subcellular fractions of a rat liver homogenate by means of differential centrifugation. In the fractions obtained (heavy mitochondrial, light mitochondrial, microsomal and cytosolic) the activities of different marker enzymes were measured as well as the activity of DPD. These results showed that almost all of the activity of DPD was located in the cytosolic fraction. To exclude any particulate-associated DPD, a light mitochondrial fraction was subsequently subjected to equilibrium density gradient centrifugation. The distribution profile of the activity of DPD and the various marker enzymes indicated that DPD from rat liver was exclusively located in the cytosol since no significant activity of DPD could be detected in any subcellular organelle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9348115     DOI: 10.1515/bchm.1997.378.9.1047

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  4 in total

1.  Severe 5-fluorouracil toxicity caused by reduced dihydropyrimidine dehydrogenase activity due to heterozygosity for a G-->A point mutation.

Authors:  A B van Kuilenburg; P Vreken; L V Beex; R A De Abreu; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

2.  Novel disease-causing mutations in the dihydropyrimidine dehydrogenase gene interpreted by analysis of the three-dimensional protein structure.

Authors:  André B P van Kuilenburg; Doreen Dobritzsch; Rutger Meinsma; Janet Haasjes; Hans R Waterham; Malgorzata J M Nowaczyk; George D Maropoulos; Guido Hein; Hermann Kalhoff; Jean M Kirk; Holger Baaske; Anne Aukett; John A Duley; Kate P Ward; Ylva Lindqvist; Albert H van Gennip
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

3.  Profound variation in dihydropyrimidine dehydrogenase activity in human blood cells: major implications for the detection of partly deficient patients.

Authors:  A B Van Kuilenburg; H van Lenthe; M J Blom; E P Mul; A H Van Gennip
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

4.  Local Irradiation Modulates the Pharmacokinetics of Metabolites in 5-Fluorouracil-Radiotherapy-Pharmacokinetics Phenomenon.

Authors:  Ju-Han Liu; Tung-Hu Tsai; Yu-Jen Chen; Li-Ying Wang; Hsin-Yu Liu; Chen-Hsi Hsieh
Journal:  Front Pharmacol       Date:  2020-02-27       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.